South and Central America Supraglottic Devices Market Outlook (2022-2033)

The South and Central America Supraglottic Devices market size is expected to reach US$ 110.1 million by 2033 from US$ 85.0 million in 2025. The market is estimated to record a CAGR of 3.3% from 2026 to 2033.

Executive Summary and South and Central America Supraglottic Devices Market Analysis:

The South and Central America supraglottic devices market is gradually evolving, driven by a combination of increasing surgical volumes, rising awareness of advanced airway management techniques, and ongoing modernization of healthcare facilities. Supraglottic airways have increasingly become popular in local hospitals and independent surgical facilities as professionals have become aware of the advantages that come with such equipment when performing procedures and administering anesthesia. In addition, training courses for anesthesiologists and emergency medical technicians have been developed, thus helping enhance the proficiency level among medical practitioners. Moreover, the current emphasis in the region towards patient safety and infection prevention is driving the adoption of disposable supraglottic airways in urban hospitals.

Despite these positive trends, there is a significant disparity in healthcare infrastructure between urban and rural areas, leading to uneven adoption of advanced airway technologies. In some regions, limited budgets and resource constraints encourage the use of traditional reusable devices, which can slow the penetration of newer supraglottic alternatives. Furthermore, a shortage of trained personnel in rural hospitals can limit the practical deployment of these devices in emergency or critical care scenarios. Increasing investment in hospital modernization, professional training initiatives, and gradual standardization of clinical protocols are expected to support steady growth in the market across South and Central America.

South and Central America Supraglottic Devices Market - Strategic Insights:

South and Central America Supraglottic Devices Market Segmentation Analysis:

Key segments that contributed to the derivation of the South and Central America Supraglottic Devices market analysis are product type, usage type, application, patient type, and end user.

• By product type, the supraglottic devices market is segmented into laryngeal mask airways, laryngeal tubes, and other product types. The laryngeal mask airways segment dominated the market in 2025.
• Based on usage type, the supraglottic devices market is classified into disposable devices and reusable devices. The disposable devices segment dominated the market in 2025.
• In terms of application, the supraglottic devices market is categorized into anesthesia, critical care, emergency medicine, and other applications. The anesthesia segment dominated the market in 2025.
• By patient type, the supraglottic devices market is bifurcated into adult and pediatric. The adult segment dominated the market in 2025.
• Based on end user, the supraglottic devices market is segmented into hospitals, ambulatory surgical centers, emergency medical services, and other end users. The hospitals segment dominated the market in 2025.

South and Central America Supraglottic Devices Market Drivers and Opportunities:

Boost in Demand for Low-Invasive Airway Devices

The South and Central America supraglottic devices market is seeing a notable boost in demand for low-invasive airway devices as healthcare providers focus on improving procedural efficiency and patient outcomes. Supraglottic airway devices (SGAs) are increasingly preferred for their simplicity, rapid placement, and reliability, particularly in emergency and perioperative care. In hospitals managing high patient volumes or limited anesthesiology staff, these devices offer a practical solution for achieving effective ventilation without extensive technical expertise.

The rising number of outpatient surgeries and short-stay procedures is a key factor driving adoption. SGAs allow quicker airway access and reduced anesthesia time, supporting enhanced patient throughput and streamlined surgical workflows. Hospitals benefit from devices that are versatile enough for both routine operations and emergency interventions, helping healthcare providers optimize operational efficiency while maintaining high safety standards.

Affordability and infection control considerations also contribute to the trend. Single-use SGAs help reduce cross-contamination risks and minimize sterilization requirements, which is particularly relevant for hospitals operating with resource constraints. Ergonomic and improved-sealing designs further enhance clinical reliability and patient comfort, positioning SGAs as a preferred choice for low-invasive airway management in the region.

Scaling Adoption of Simulation-Focused Training Practices

Simulation-focused training practices are increasingly driving the use of supraglottic airway devices across South and Central America. Healthcare institutions are adopting hands-on training programs that allow clinicians to practice device insertion, troubleshoot complications, and refine decision-making in a controlled environment. This approach is critical in regions where clinical exposure to advanced airway cases may be inconsistent, ensuring that staff maintain competency and confidence in real-world scenarios.

Structured workshops and scenario-driven training modules are becoming more prevalent. Clinicians gain practical experience with a variety of SGAs and patient conditions, reinforcing standardized airway management protocols and improving team coordination. This approach supports multidisciplinary training, allowing doctors, nurses, and emergency responders to work together efficiently during critical interventions.

The accessibility of simulation training is also improving, even in smaller or remote healthcare facilities. Mobile simulation units, modular low-cost models, and peer-led workshops enable wider staff participation, helping maintain clinical proficiency across diverse care settings. Regular practice in realistic scenarios builds technical expertise, confidence, and consistency in airway management, thereby supporting the continued expansion of supraglottic device use throughout South and Central America.

South and Central America Supraglottic Devices Market Size and Share Analysis:

The South and Central America Supraglottic Devices market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report evaluates important subsegments categorized within product type, usage type, application, patient type, and end user, highlighting their respective contributions to overall market performance.

By product type, the laryngeal mask airways subsegment dominated the supraglottic devices market in 2025. The dominance of laryngeal mask airways is driven by their ease of insertion, high success rate in securing the airway, reduced risk of complications compared to traditional intubation, and broad adoption in surgical and emergency settings, making them a key revenue contributor for manufacturers.

Based on usage type, the disposable devices subsegment led the market in 2025. Disposable supraglottic devices are preferred due to their reduced risk of cross-contamination, lower sterilization requirements, and convenience for high-volume clinical environments, which supports their widespread adoption across hospitals and emergency care facilities.

In terms of application, the anesthesia subsegment dominated the market in 2025. This leadership is attributed to the frequent use of supraglottic devices in elective and emergency surgical procedures, the increasing number of surgeries worldwide, and the clinical benefits of providing a safe and effective airway without the need for invasive intubation.

By patient type, the adult subsegment dominated the market in 2025. The preference for adult patients is driven by higher procedural volumes in adult surgeries, the established clinical efficacy of supraglottic devices in adult airway management, and increasing adoption in critical care and emergency settings.

Based on end user, the hospitals subsegment dominated the market in 2025. Hospitals lead due to their well-established anesthesia and critical care departments, access to advanced airway management devices, trained staff, and the capability to perform a high volume of surgical and emergency procedures requiring reliable airway management.

South and Central America Supraglottic Devices Market Report Highlights:

South and Central America Supraglottic Devices Market Report Coverage and Deliverables:

The "South and Central America Supraglottic Devices Market Size and Forecast (2022–2033)" report provides a detailed analysis of the market covering below areas:

• South and Central America Supraglottic Devices market size and forecast at regional and country levels for all market segments covered under the scope
• South and Central America Supraglottic Devices market trends, as well as drivers, restraints, and opportunities
• South and Central America Supraglottic Devices market analysis covering key trends, regional framework, major players, regulations, and recent developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the South and Central America Supraglottic Devices market
• Detailed company profiles, including SWOT analysis

South and Central America Supraglottic Devices Market Geographic Insights:

The geographical scope of the South and Central America Supraglottic Devices market report is divided into: Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. Brazil held the largest share in 2025.

Brazil holds the most dominant position in the market for supraglottic airway devices in South and Central America because of the development of its healthcare industry, high number of surgical procedures, and widespread use of innovative techniques of airway management. The introduction of supraglottic airway devices is growing among city hospitals, not only for elective surgeries but also for emergencies, because the procedure takes less time and effort than traditional intubation.

A key driver in Brazil is the country’s network of private hospitals and specialty surgical centers, which tend to adopt newer airway management tools more quickly than public hospitals. Moreover, professional bodies and societies of anesthesiologists are aggressively supporting training sessions and workshops related to airway management, which will ensure that the medical professionals use the supraglottic devices confidently on different types of patients. EMS systems operating in the cities have started to use supraglottic devices in their pre-hospital management strategies. Despite some difficulties because of budget constraints and infrastructural problems in rural locations, Brazil is the most important market in South and Central America for supraglottic devices.

South and Central America Supraglottic Devices Market Research Report Guidance:

• The report includes qualitative and quantitative data in the South and Central America Supraglottic Devices market across product type, usage type, application, patient type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the South and Central America Supraglottic Devices market.
• Chapter 3 focuses on the research methodology of the study.
• Chapter 4 includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the South and Central America Supraglottic Devices market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the South and Central America Supraglottic Devices market scenario, in terms of historical market revenues, and forecast till the year 2033.
• Chapters 7 to 12 cover South and Central America Supraglottic Devices market segments by product type, usage type, application, patient type, end user, and geography across Brazil, Argentina, Chile, Colombia, Peru, and the Rest of South and Central America. They cover the market revenue, forecast, and factors driving the market.
• Chapter 13 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 14 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 15 provides detailed profiles of the major companies operating in the South and Central America Supraglottic Devices market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 16, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

South and Central America Supraglottic Devices Market News and Key Development:

The South and Central America Supraglottic Devices market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the South and Central America Supraglottic Devices market are:

• In October 2025, Ambu A/S announced that it expanded its environmental sustainability programs, including recycling initiatives for its reusable device components reinforcing broader product lifecycle commitments that impact how its airway and anesthesia solutions (including supraglottic airway device portfolios distributed in Latin America) are managed post‑
• In May 2023, Teleflex Incorporated highlighted in its Global Impact Report strategic growth initiatives including reinforcing its airway management business (which encompasses its LMA supraglottic airway products) through expanded distribution and support programs across its global footprint that includes Latin America.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• Food and Drug Administration (FDA)
• European Database on Medical Devices (EUDAMED)
• European Society of Cardiology (ESC)
• American College of Cardiology (ACC)
• American Heart Association (AHA)
• Company Websites
• Company Annual Reports
• Company Investor Presentations